Is it true, as one critics says, that “cancer regularly innovates with proteins of novel function”?
A participant did not like that I called his origins model “idiosyncratic,” or that I characterized the reaction to it as “cautious.” Oh well.
I asked fairly innocuous questions, realizing that I was being allowed to participate as long as I didn’t cause strife.
Richard Buggs gives us a look inside the sausage factory where figures on the subject are calculated.
The issue comes down to the creative power of the unguided evolutionary mechanism, or the lack of it.